PETITION TO REVIVE-RECEIVED
received
on 11 Jun 2024
Last Applicant/ Owned by
Clonshaugh Business & Technology Park
Dublin 17
IE
D17E400
Serial Number
97773234 filed on 30th Jan 2023
Registration Number
N/A
Correspondent Address
MAIL CODE: AND-250C
IRVINE, CA 92612
United States
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
EVRYGAM
pharmaceutical preparations to treat infections; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Classification Information
Class [005]
Pharmaceutical Products
pharmaceutical preparations to treat infections; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97773234
Mark Type
No Service/Collective Mark
Attorney Docket Number
No EVRYGAM
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 11th Jun 2024 | SOU EXTENSION RECEIVED WITH TEAS PETITION |
| 05th Dec 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 10th Oct 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 10th Oct 2023 | PUBLISHED FOR OPPOSITION |
| 20th Sep 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 01st Sep 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 31st Aug 2023 | ASSIGNED TO EXAMINER |
| 16th Feb 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 02th Feb 2023 | NEW APPLICATION ENTERED |